nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—BCHE—multiple sclerosis	0.805	1	CbGaD
Ephedrine—BCHE—Triamcinolone—multiple sclerosis	0.0806	1	CbGbCtD
Ephedrine—Cerebral haemorrhage—Fingolimod—multiple sclerosis	0.00484	0.07	CcSEcCtD
Ephedrine—SLC6A2—nerve—multiple sclerosis	0.00219	0.0972	CbGeAlD
Ephedrine—Pseudoephedrine—IL2—multiple sclerosis	0.00174	0.748	CrCbGaD
Ephedrine—SLC18A2—brainstem—multiple sclerosis	0.00154	0.0684	CbGeAlD
Ephedrine—Bradycardia—Fingolimod—multiple sclerosis	0.00137	0.0198	CcSEcCtD
Ephedrine—ACHE—medulla oblongata—multiple sclerosis	0.0011	0.0489	CbGeAlD
Ephedrine—SLC18A2—medulla oblongata—multiple sclerosis	0.00107	0.0477	CbGeAlD
Ephedrine—Palpitations—Fingolimod—multiple sclerosis	0.00104	0.015	CcSEcCtD
Ephedrine—Hypertension—Fingolimod—multiple sclerosis	0.00101	0.0146	CcSEcCtD
Ephedrine—ACHE—midbrain—multiple sclerosis	0.00101	0.0447	CbGeAlD
Ephedrine—ACHE—spinal cord—multiple sclerosis	0.000982	0.0436	CbGeAlD
Ephedrine—SLC18A2—midbrain—multiple sclerosis	0.00098	0.0436	CbGeAlD
Ephedrine—SLC6A2—brainstem—multiple sclerosis	0.000939	0.0417	CbGeAlD
Ephedrine—ADRA1A—brainstem—multiple sclerosis	0.000873	0.0388	CbGeAlD
Ephedrine—Dyspnoea—Fingolimod—multiple sclerosis	0.000853	0.0123	CcSEcCtD
Ephedrine—SLC18A2—nervous system—multiple sclerosis	0.000806	0.0358	CbGeAlD
Ephedrine—ACHE—cerebellum—multiple sclerosis	0.000778	0.0346	CbGeAlD
Ephedrine—SLC18A2—central nervous system—multiple sclerosis	0.000776	0.0345	CbGeAlD
Ephedrine—BCHE—brainstem—multiple sclerosis	0.000776	0.0345	CbGeAlD
Ephedrine—SLC18A2—cerebellum—multiple sclerosis	0.000758	0.0337	CbGeAlD
Ephedrine—Euphoric mood—Prednisolone—multiple sclerosis	0.000704	0.0102	CcSEcCtD
Ephedrine—Delirium—Prednisone—multiple sclerosis	0.000693	0.01	CcSEcCtD
Ephedrine—Asthenia—Fingolimod—multiple sclerosis	0.000686	0.00991	CcSEcCtD
Ephedrine—Arrhythmia—Cladribine—multiple sclerosis	0.000682	0.00985	CcSEcCtD
Ephedrine—SLC6A2—medulla oblongata—multiple sclerosis	0.000655	0.0291	CbGeAlD
Ephedrine—Euphoric mood—Triamcinolone—multiple sclerosis	0.000648	0.00935	CcSEcCtD
Ephedrine—Euphoric mood—Methylprednisolone—multiple sclerosis	0.000646	0.00933	CcSEcCtD
Ephedrine—Dizziness—Fingolimod—multiple sclerosis	0.000633	0.00914	CcSEcCtD
Ephedrine—ACHE—brain—multiple sclerosis	0.000632	0.0281	CbGeAlD
Ephedrine—SLC18A2—brain—multiple sclerosis	0.000616	0.0274	CbGeAlD
Ephedrine—Headache—Fingolimod—multiple sclerosis	0.000599	0.00866	CcSEcCtD
Ephedrine—Euphoric mood—Dexamethasone—multiple sclerosis	0.000588	0.00849	CcSEcCtD
Ephedrine—Euphoric mood—Betamethasone—multiple sclerosis	0.000588	0.00849	CcSEcCtD
Ephedrine—Pseudoephedrine—TNF—multiple sclerosis	0.000588	0.252	CrCbGaD
Ephedrine—Chest pain—Cladribine—multiple sclerosis	0.000566	0.00817	CcSEcCtD
Ephedrine—Anxiety—Cladribine—multiple sclerosis	0.000564	0.00814	CcSEcCtD
Ephedrine—Arrhythmia—Azathioprine—multiple sclerosis	0.000554	0.00801	CcSEcCtD
Ephedrine—Confusional state—Cladribine—multiple sclerosis	0.000547	0.0079	CcSEcCtD
Ephedrine—BCHE—medulla oblongata—multiple sclerosis	0.000541	0.024	CbGeAlD
Ephedrine—Sweating—Mitoxantrone—multiple sclerosis	0.000536	0.00774	CcSEcCtD
Ephedrine—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.000533	0.0077	CcSEcCtD
Ephedrine—Tachycardia—Cladribine—multiple sclerosis	0.000529	0.00764	CcSEcCtD
Ephedrine—Hyperhidrosis—Cladribine—multiple sclerosis	0.000524	0.00757	CcSEcCtD
Ephedrine—Irritability—Methylprednisolone—multiple sclerosis	0.000521	0.00753	CcSEcCtD
Ephedrine—Anorexia—Cladribine—multiple sclerosis	0.000517	0.00747	CcSEcCtD
Ephedrine—Euphoric mood—Prednisone—multiple sclerosis	0.000512	0.00739	CcSEcCtD
Ephedrine—Bradycardia—Mitoxantrone—multiple sclerosis	0.000511	0.00738	CcSEcCtD
Ephedrine—BCHE—midbrain—multiple sclerosis	0.000494	0.022	CbGeAlD
Ephedrine—SLC6A2—nervous system—multiple sclerosis	0.000492	0.0219	CbGeAlD
Ephedrine—Insomnia—Cladribine—multiple sclerosis	0.000491	0.00708	CcSEcCtD
Ephedrine—Psychotic disorder—Dexamethasone—multiple sclerosis	0.000485	0.007	CcSEcCtD
Ephedrine—Psychotic disorder—Betamethasone—multiple sclerosis	0.000485	0.007	CcSEcCtD
Ephedrine—Dyspnoea—Cladribine—multiple sclerosis	0.000484	0.00698	CcSEcCtD
Ephedrine—BCHE—spinal cord—multiple sclerosis	0.000482	0.0214	CbGeAlD
Ephedrine—Irritability—Dexamethasone—multiple sclerosis	0.000474	0.00684	CcSEcCtD
Ephedrine—Irritability—Betamethasone—multiple sclerosis	0.000474	0.00684	CcSEcCtD
Ephedrine—SLC6A2—central nervous system—multiple sclerosis	0.000474	0.021	CbGeAlD
Ephedrine—Decreased appetite—Cladribine—multiple sclerosis	0.000471	0.00681	CcSEcCtD
Ephedrine—Pain—Cladribine—multiple sclerosis	0.000464	0.0067	CcSEcCtD
Ephedrine—ADRA1A—nervous system—multiple sclerosis	0.000457	0.0203	CbGeAlD
Ephedrine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000448	0.00647	CcSEcCtD
Ephedrine—Feeling abnormal—Cladribine—multiple sclerosis	0.000447	0.00645	CcSEcCtD
Ephedrine—ADRA1A—central nervous system—multiple sclerosis	0.00044	0.0196	CbGeAlD
Ephedrine—ADRA1A—cerebellum—multiple sclerosis	0.00043	0.0191	CbGeAlD
Ephedrine—Body temperature increased—Cladribine—multiple sclerosis	0.000429	0.00619	CcSEcCtD
Ephedrine—Psychotic disorder—Prednisone—multiple sclerosis	0.000422	0.0061	CcSEcCtD
Ephedrine—Bradycardia—Prednisolone—multiple sclerosis	0.000419	0.00605	CcSEcCtD
Ephedrine—Irritability—Prednisone—multiple sclerosis	0.000413	0.00596	CcSEcCtD
Ephedrine—BCHE—nervous system—multiple sclerosis	0.000406	0.0181	CbGeAlD
Ephedrine—Sweating—Methylprednisolone—multiple sclerosis	0.000403	0.00583	CcSEcCtD
Ephedrine—BCHE—central nervous system—multiple sclerosis	0.000391	0.0174	CbGeAlD
Ephedrine—Asthenia—Cladribine—multiple sclerosis	0.000389	0.00562	CcSEcCtD
Ephedrine—Bradycardia—Triamcinolone—multiple sclerosis	0.000385	0.00557	CcSEcCtD
Ephedrine—Bradycardia—Methylprednisolone—multiple sclerosis	0.000385	0.00555	CcSEcCtD
Ephedrine—BCHE—cerebellum—multiple sclerosis	0.000383	0.017	CbGeAlD
Ephedrine—Hypertension—Mitoxantrone—multiple sclerosis	0.000377	0.00545	CcSEcCtD
Ephedrine—SLC6A2—brain—multiple sclerosis	0.000376	0.0167	CbGeAlD
Ephedrine—Hallucination—Methylprednisolone—multiple sclerosis	0.000376	0.00543	CcSEcCtD
Ephedrine—Chest pain—Mitoxantrone—multiple sclerosis	0.000372	0.00537	CcSEcCtD
Ephedrine—Anxiety—Mitoxantrone—multiple sclerosis	0.000371	0.00535	CcSEcCtD
Ephedrine—Arrhythmia—Prednisolone—multiple sclerosis	0.000368	0.00531	CcSEcCtD
Ephedrine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000363	0.00525	CcSEcCtD
Ephedrine—Confusional state—Mitoxantrone—multiple sclerosis	0.000359	0.00519	CcSEcCtD
Ephedrine—Dizziness—Cladribine—multiple sclerosis	0.000359	0.00518	CcSEcCtD
Ephedrine—Bradycardia—Dexamethasone—multiple sclerosis	0.00035	0.00505	CcSEcCtD
Ephedrine—Bradycardia—Betamethasone—multiple sclerosis	0.00035	0.00505	CcSEcCtD
Ephedrine—ADRA1A—brain—multiple sclerosis	0.000349	0.0155	CbGeAlD
Ephedrine—Body temperature increased—Azathioprine—multiple sclerosis	0.000349	0.00503	CcSEcCtD
Ephedrine—Tachycardia—Mitoxantrone—multiple sclerosis	0.000348	0.00502	CcSEcCtD
Ephedrine—Irritability—Methotrexate—multiple sclerosis	0.000345	0.00498	CcSEcCtD
Ephedrine—Vomiting—Cladribine—multiple sclerosis	0.000345	0.00498	CcSEcCtD
Ephedrine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000345	0.00498	CcSEcCtD
Ephedrine—Rash—Cladribine—multiple sclerosis	0.000342	0.00494	CcSEcCtD
Ephedrine—Hallucination—Dexamethasone—multiple sclerosis	0.000342	0.00494	CcSEcCtD
Ephedrine—Hallucination—Betamethasone—multiple sclerosis	0.000342	0.00494	CcSEcCtD
Ephedrine—Dermatitis—Cladribine—multiple sclerosis	0.000342	0.00493	CcSEcCtD
Ephedrine—Anorexia—Mitoxantrone—multiple sclerosis	0.00034	0.00491	CcSEcCtD
Ephedrine—Headache—Cladribine—multiple sclerosis	0.00034	0.00491	CcSEcCtD
Ephedrine—Arrhythmia—Triamcinolone—multiple sclerosis	0.000338	0.00488	CcSEcCtD
Ephedrine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000337	0.00487	CcSEcCtD
Ephedrine—Nausea—Cladribine—multiple sclerosis	0.000322	0.00465	CcSEcCtD
Ephedrine—Vertigo—Prednisolone—multiple sclerosis	0.000322	0.00465	CcSEcCtD
Ephedrine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000318	0.00459	CcSEcCtD
Ephedrine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000314	0.00453	CcSEcCtD
Ephedrine—BCHE—brain—multiple sclerosis	0.000311	0.0138	CbGeAlD
Ephedrine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00031	0.00448	CcSEcCtD
Ephedrine—Hypertension—Prednisolone—multiple sclerosis	0.000309	0.00447	CcSEcCtD
Ephedrine—Arrhythmia—Dexamethasone—multiple sclerosis	0.000307	0.00443	CcSEcCtD
Ephedrine—Arrhythmia—Betamethasone—multiple sclerosis	0.000307	0.00443	CcSEcCtD
Ephedrine—Pain—Mitoxantrone—multiple sclerosis	0.000305	0.0044	CcSEcCtD
Ephedrine—Bradycardia—Prednisone—multiple sclerosis	0.000305	0.0044	CcSEcCtD
Ephedrine—Hallucination—Prednisone—multiple sclerosis	0.000298	0.0043	CcSEcCtD
Ephedrine—Vertigo—Triamcinolone—multiple sclerosis	0.000296	0.00428	CcSEcCtD
Ephedrine—Vertigo—Methylprednisolone—multiple sclerosis	0.000295	0.00427	CcSEcCtD
Ephedrine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000294	0.00424	CcSEcCtD
Ephedrine—Dysuria—Methotrexate—multiple sclerosis	0.000292	0.00422	CcSEcCtD
Ephedrine—Dizziness—Azathioprine—multiple sclerosis	0.000292	0.00421	CcSEcCtD
Ephedrine—Tachycardia—Prednisolone—multiple sclerosis	0.000285	0.00412	CcSEcCtD
Ephedrine—Hypertension—Triamcinolone—multiple sclerosis	0.000285	0.00411	CcSEcCtD
Ephedrine—Hypertension—Methylprednisolone—multiple sclerosis	0.000284	0.0041	CcSEcCtD
Ephedrine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000283	0.00408	CcSEcCtD
Ephedrine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000282	0.00407	CcSEcCtD
Ephedrine—Vomiting—Azathioprine—multiple sclerosis	0.00028	0.00405	CcSEcCtD
Ephedrine—Anxiety—Methylprednisolone—multiple sclerosis	0.000279	0.00403	CcSEcCtD
Ephedrine—Rash—Azathioprine—multiple sclerosis	0.000278	0.00402	CcSEcCtD
Ephedrine—Dermatitis—Azathioprine—multiple sclerosis	0.000278	0.00401	CcSEcCtD
Ephedrine—Headache—Azathioprine—multiple sclerosis	0.000276	0.00399	CcSEcCtD
Ephedrine—Confusional state—Methylprednisolone—multiple sclerosis	0.000271	0.00391	CcSEcCtD
Ephedrine—Vertigo—Dexamethasone—multiple sclerosis	0.000269	0.00388	CcSEcCtD
Ephedrine—Vertigo—Betamethasone—multiple sclerosis	0.000269	0.00388	CcSEcCtD
Ephedrine—Arrhythmia—Prednisone—multiple sclerosis	0.000267	0.00386	CcSEcCtD
Ephedrine—Sweating—Methotrexate—multiple sclerosis	0.000267	0.00386	CcSEcCtD
Ephedrine—Insomnia—Prednisolone—multiple sclerosis	0.000265	0.00382	CcSEcCtD
Ephedrine—Tachycardia—Triamcinolone—multiple sclerosis	0.000262	0.00379	CcSEcCtD
Ephedrine—Nausea—Azathioprine—multiple sclerosis	0.000262	0.00378	CcSEcCtD
Ephedrine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000262	0.00378	CcSEcCtD
Ephedrine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00026	0.00376	CcSEcCtD
Ephedrine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000259	0.00375	CcSEcCtD
Ephedrine—Hypertension—Dexamethasone—multiple sclerosis	0.000258	0.00373	CcSEcCtD
Ephedrine—Hypertension—Betamethasone—multiple sclerosis	0.000258	0.00373	CcSEcCtD
Ephedrine—Asthenia—Mitoxantrone—multiple sclerosis	0.000256	0.00369	CcSEcCtD
Ephedrine—Anxiety—Dexamethasone—multiple sclerosis	0.000254	0.00366	CcSEcCtD
Ephedrine—Anxiety—Betamethasone—multiple sclerosis	0.000254	0.00366	CcSEcCtD
Ephedrine—Pain—Prednisolone—multiple sclerosis	0.00025	0.00361	CcSEcCtD
Ephedrine—Insomnia—Triamcinolone—multiple sclerosis	0.000243	0.00351	CcSEcCtD
Ephedrine—Insomnia—Methylprednisolone—multiple sclerosis	0.000243	0.00351	CcSEcCtD
Ephedrine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000241	0.00348	CcSEcCtD
Ephedrine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00024	0.00346	CcSEcCtD
Ephedrine—Agitation—Prednisone—multiple sclerosis	0.000239	0.00346	CcSEcCtD
Ephedrine—Tachycardia—Betamethasone—multiple sclerosis	0.000238	0.00344	CcSEcCtD
Ephedrine—Tachycardia—Dexamethasone—multiple sclerosis	0.000238	0.00344	CcSEcCtD
Ephedrine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000237	0.00342	CcSEcCtD
Ephedrine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000236	0.00341	CcSEcCtD
Ephedrine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000236	0.00341	CcSEcCtD
Ephedrine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000236	0.00341	CcSEcCtD
Ephedrine—Vertigo—Prednisone—multiple sclerosis	0.000234	0.00338	CcSEcCtD
Ephedrine—Anorexia—Dexamethasone—multiple sclerosis	0.000233	0.00336	CcSEcCtD
Ephedrine—Anorexia—Betamethasone—multiple sclerosis	0.000233	0.00336	CcSEcCtD
Ephedrine—Pain—Triamcinolone—multiple sclerosis	0.00023	0.00332	CcSEcCtD
Ephedrine—Vomiting—Mitoxantrone—multiple sclerosis	0.000227	0.00327	CcSEcCtD
Ephedrine—Hypertension—Prednisone—multiple sclerosis	0.000225	0.00325	CcSEcCtD
Ephedrine—Rash—Mitoxantrone—multiple sclerosis	0.000225	0.00325	CcSEcCtD
Ephedrine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000225	0.00324	CcSEcCtD
Ephedrine—Headache—Mitoxantrone—multiple sclerosis	0.000223	0.00323	CcSEcCtD
Ephedrine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000222	0.0032	CcSEcCtD
Ephedrine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000221	0.00319	CcSEcCtD
Ephedrine—Anxiety—Prednisone—multiple sclerosis	0.000221	0.00319	CcSEcCtD
Ephedrine—Insomnia—Dexamethasone—multiple sclerosis	0.000221	0.00319	CcSEcCtD
Ephedrine—Insomnia—Betamethasone—multiple sclerosis	0.000221	0.00319	CcSEcCtD
Ephedrine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000215	0.0031	CcSEcCtD
Ephedrine—Dyspepsia—Betamethasone—multiple sclerosis	0.000215	0.0031	CcSEcCtD
Ephedrine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000213	0.00307	CcSEcCtD
Ephedrine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000212	0.00306	CcSEcCtD
Ephedrine—Decreased appetite—Betamethasone—multiple sclerosis	0.000212	0.00306	CcSEcCtD
Ephedrine—Nausea—Mitoxantrone—multiple sclerosis	0.000212	0.00306	CcSEcCtD
Ephedrine—Pain—Dexamethasone—multiple sclerosis	0.000209	0.00301	CcSEcCtD
Ephedrine—Pain—Betamethasone—multiple sclerosis	0.000209	0.00301	CcSEcCtD
Ephedrine—Tachycardia—Prednisone—multiple sclerosis	0.000207	0.003	CcSEcCtD
Ephedrine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000205	0.00297	CcSEcCtD
Ephedrine—Anorexia—Prednisone—multiple sclerosis	0.000203	0.00293	CcSEcCtD
Ephedrine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000201	0.0029	CcSEcCtD
Ephedrine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000201	0.0029	CcSEcCtD
Ephedrine—Vertigo—Methotrexate—multiple sclerosis	0.000196	0.00282	CcSEcCtD
Ephedrine—Dizziness—Prednisolone—multiple sclerosis	0.000193	0.00279	CcSEcCtD
Ephedrine—Asthenia—Triamcinolone—multiple sclerosis	0.000193	0.00279	CcSEcCtD
Ephedrine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000193	0.00279	CcSEcCtD
Ephedrine—Body temperature increased—Betamethasone—multiple sclerosis	0.000193	0.00279	CcSEcCtD
Ephedrine—Asthenia—Methylprednisolone—multiple sclerosis	0.000193	0.00278	CcSEcCtD
Ephedrine—Insomnia—Prednisone—multiple sclerosis	0.000192	0.00278	CcSEcCtD
Ephedrine—Dyspepsia—Prednisone—multiple sclerosis	0.000187	0.0027	CcSEcCtD
Ephedrine—Chest pain—Methotrexate—multiple sclerosis	0.000185	0.00268	CcSEcCtD
Ephedrine—Decreased appetite—Prednisone—multiple sclerosis	0.000185	0.00267	CcSEcCtD
Ephedrine—Rash—Prednisolone—multiple sclerosis	0.000184	0.00266	CcSEcCtD
Ephedrine—Dermatitis—Prednisolone—multiple sclerosis	0.000184	0.00266	CcSEcCtD
Ephedrine—Headache—Prednisolone—multiple sclerosis	0.000183	0.00265	CcSEcCtD
Ephedrine—Confusional state—Methotrexate—multiple sclerosis	0.000179	0.00259	CcSEcCtD
Ephedrine—Dizziness—Triamcinolone—multiple sclerosis	0.000178	0.00257	CcSEcCtD
Ephedrine—Dizziness—Methylprednisolone—multiple sclerosis	0.000177	0.00256	CcSEcCtD
Ephedrine—Feeling abnormal—Prednisone—multiple sclerosis	0.000175	0.00253	CcSEcCtD
Ephedrine—Asthenia—Dexamethasone—multiple sclerosis	0.000175	0.00253	CcSEcCtD
Ephedrine—Asthenia—Betamethasone—multiple sclerosis	0.000175	0.00253	CcSEcCtD
Ephedrine—Nausea—Prednisolone—multiple sclerosis	0.000174	0.00251	CcSEcCtD
Ephedrine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000172	0.00248	CcSEcCtD
Ephedrine—Vomiting—Triamcinolone—multiple sclerosis	0.000171	0.00247	CcSEcCtD
Ephedrine—Vomiting—Methylprednisolone—multiple sclerosis	0.000171	0.00246	CcSEcCtD
Ephedrine—Rash—Triamcinolone—multiple sclerosis	0.00017	0.00245	CcSEcCtD
Ephedrine—Dermatitis—Triamcinolone—multiple sclerosis	0.000169	0.00245	CcSEcCtD
Ephedrine—Anorexia—Methotrexate—multiple sclerosis	0.000169	0.00245	CcSEcCtD
Ephedrine—Rash—Methylprednisolone—multiple sclerosis	0.000169	0.00244	CcSEcCtD
Ephedrine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000169	0.00244	CcSEcCtD
Ephedrine—Headache—Triamcinolone—multiple sclerosis	0.000168	0.00243	CcSEcCtD
Ephedrine—Headache—Methylprednisolone—multiple sclerosis	0.000168	0.00243	CcSEcCtD
Ephedrine—Body temperature increased—Prednisone—multiple sclerosis	0.000168	0.00243	CcSEcCtD
Ephedrine—Dizziness—Betamethasone—multiple sclerosis	0.000161	0.00233	CcSEcCtD
Ephedrine—Dizziness—Dexamethasone—multiple sclerosis	0.000161	0.00233	CcSEcCtD
Ephedrine—Insomnia—Methotrexate—multiple sclerosis	0.000161	0.00232	CcSEcCtD
Ephedrine—Nausea—Triamcinolone—multiple sclerosis	0.00016	0.00231	CcSEcCtD
Ephedrine—Nausea—Methylprednisolone—multiple sclerosis	0.000159	0.0023	CcSEcCtD
Ephedrine—Dyspnoea—Methotrexate—multiple sclerosis	0.000158	0.00229	CcSEcCtD
Ephedrine—Dyspepsia—Methotrexate—multiple sclerosis	0.000156	0.00226	CcSEcCtD
Ephedrine—Vomiting—Betamethasone—multiple sclerosis	0.000155	0.00224	CcSEcCtD
Ephedrine—Vomiting—Dexamethasone—multiple sclerosis	0.000155	0.00224	CcSEcCtD
Ephedrine—Decreased appetite—Methotrexate—multiple sclerosis	0.000154	0.00223	CcSEcCtD
Ephedrine—Rash—Dexamethasone—multiple sclerosis	0.000154	0.00222	CcSEcCtD
Ephedrine—Rash—Betamethasone—multiple sclerosis	0.000154	0.00222	CcSEcCtD
Ephedrine—Dermatitis—Dexamethasone—multiple sclerosis	0.000154	0.00222	CcSEcCtD
Ephedrine—Dermatitis—Betamethasone—multiple sclerosis	0.000154	0.00222	CcSEcCtD
Ephedrine—Headache—Dexamethasone—multiple sclerosis	0.000153	0.00221	CcSEcCtD
Ephedrine—Headache—Betamethasone—multiple sclerosis	0.000153	0.00221	CcSEcCtD
Ephedrine—Asthenia—Prednisone—multiple sclerosis	0.000152	0.0022	CcSEcCtD
Ephedrine—Pain—Methotrexate—multiple sclerosis	0.000152	0.00219	CcSEcCtD
Ephedrine—Feeling abnormal—Methotrexate—multiple sclerosis	0.000146	0.00211	CcSEcCtD
Ephedrine—Nausea—Betamethasone—multiple sclerosis	0.000145	0.00209	CcSEcCtD
Ephedrine—Nausea—Dexamethasone—multiple sclerosis	0.000145	0.00209	CcSEcCtD
Ephedrine—Dizziness—Prednisone—multiple sclerosis	0.000141	0.00203	CcSEcCtD
Ephedrine—Body temperature increased—Methotrexate—multiple sclerosis	0.00014	0.00203	CcSEcCtD
Ephedrine—Vomiting—Prednisone—multiple sclerosis	0.000135	0.00195	CcSEcCtD
Ephedrine—Rash—Prednisone—multiple sclerosis	0.000134	0.00194	CcSEcCtD
Ephedrine—Dermatitis—Prednisone—multiple sclerosis	0.000134	0.00193	CcSEcCtD
Ephedrine—Headache—Prednisone—multiple sclerosis	0.000133	0.00192	CcSEcCtD
Ephedrine—Asthenia—Methotrexate—multiple sclerosis	0.000127	0.00184	CcSEcCtD
Ephedrine—Nausea—Prednisone—multiple sclerosis	0.000126	0.00182	CcSEcCtD
Ephedrine—Dizziness—Methotrexate—multiple sclerosis	0.000117	0.0017	CcSEcCtD
Ephedrine—Vomiting—Methotrexate—multiple sclerosis	0.000113	0.00163	CcSEcCtD
Ephedrine—Rash—Methotrexate—multiple sclerosis	0.000112	0.00162	CcSEcCtD
Ephedrine—Dermatitis—Methotrexate—multiple sclerosis	0.000112	0.00162	CcSEcCtD
Ephedrine—Headache—Methotrexate—multiple sclerosis	0.000111	0.00161	CcSEcCtD
Ephedrine—Nausea—Methotrexate—multiple sclerosis	0.000105	0.00152	CcSEcCtD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	6.94e-05	0.00347	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	6.72e-05	0.00336	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	6.49e-05	0.00325	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—SLC30A7—multiple sclerosis	6.45e-05	0.00323	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCL13—multiple sclerosis	6.39e-05	0.0032	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CCR1—multiple sclerosis	6.39e-05	0.0032	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	6.31e-05	0.00316	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	6.26e-05	0.00313	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	5.98e-05	0.00299	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	5.82e-05	0.00291	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SRM—multiple sclerosis	5.79e-05	0.0029	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—GPR65—multiple sclerosis	5.78e-05	0.00289	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—SLC30A7—multiple sclerosis	5.76e-05	0.00288	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	5.76e-05	0.00288	CbGpPWpGaD
Ephedrine—ADRB2—G alpha (s) signalling events—POMC—multiple sclerosis	5.71e-05	0.00286	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	5.56e-05	0.00278	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	5.56e-05	0.00278	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.55e-05	0.00278	CbGpPWpGaD
Ephedrine—ACHE—ATF-2 transcription factor network—IL6—multiple sclerosis	5.49e-05	0.00275	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	5.41e-05	0.00271	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	5.37e-05	0.00268	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CCR1—multiple sclerosis	5.29e-05	0.00264	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL13—multiple sclerosis	5.29e-05	0.00264	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	5.22e-05	0.00261	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—PABPC1—multiple sclerosis	5.22e-05	0.00261	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SRM—multiple sclerosis	5.17e-05	0.00258	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.17e-05	0.00258	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	4.99e-05	0.0025	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	4.95e-05	0.00247	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.91e-05	0.00245	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—S1PR1—multiple sclerosis	4.9e-05	0.00245	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	4.82e-05	0.00241	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	4.76e-05	0.00238	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—RPL5—multiple sclerosis	4.71e-05	0.00236	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—PABPC1—multiple sclerosis	4.66e-05	0.00233	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	4.6e-05	0.0023	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CCL3—multiple sclerosis	4.55e-05	0.00228	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	4.49e-05	0.00225	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	4.47e-05	0.00224	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—S1PR1—multiple sclerosis	4.45e-05	0.00223	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—PTGER4—multiple sclerosis	4.38e-05	0.00219	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCR3—multiple sclerosis	4.23e-05	0.00212	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—RPL5—multiple sclerosis	4.2e-05	0.0021	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—RGS1—multiple sclerosis	4.16e-05	0.00208	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	4.13e-05	0.00206	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CCR2—multiple sclerosis	4.12e-05	0.00206	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP27B1—multiple sclerosis	4.08e-05	0.00204	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CYP24A1—multiple sclerosis	4.08e-05	0.00204	CbGpPWpGaD
Ephedrine—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	4.07e-05	0.00203	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—S1PR1—multiple sclerosis	4.05e-05	0.00203	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.99e-05	0.002	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	3.95e-05	0.00198	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—GPR65—multiple sclerosis	3.95e-05	0.00198	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	3.87e-05	0.00193	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CNR1—multiple sclerosis	3.8e-05	0.0019	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—RGS1—multiple sclerosis	3.78e-05	0.00189	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CCL3—multiple sclerosis	3.77e-05	0.00188	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GPC5—multiple sclerosis	3.73e-05	0.00187	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	3.72e-05	0.00186	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—S1PR1—multiple sclerosis	3.68e-05	0.00184	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP27B1—multiple sclerosis	3.64e-05	0.00182	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP24A1—multiple sclerosis	3.64e-05	0.00182	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—PTGER4—multiple sclerosis	3.63e-05	0.00181	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL13—multiple sclerosis	3.61e-05	0.00181	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CCR1—multiple sclerosis	3.61e-05	0.00181	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—GPR65—multiple sclerosis	3.59e-05	0.00179	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCR3—multiple sclerosis	3.5e-05	0.00175	CbGpPWpGaD
Ephedrine—SLC6A2—NRF2 pathway—TGFB1—multiple sclerosis	3.49e-05	0.00175	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	3.48e-05	0.00174	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.48e-05	0.00174	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LINGO1—multiple sclerosis	3.47e-05	0.00173	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—BCHE—multiple sclerosis	3.45e-05	0.00172	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—RGS1—multiple sclerosis	3.44e-05	0.00172	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCL10—multiple sclerosis	3.42e-05	0.00171	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CCR2—multiple sclerosis	3.41e-05	0.0017	CbGpPWpGaD
Ephedrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	3.36e-05	0.00168	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPC5—multiple sclerosis	3.33e-05	0.00167	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL13—multiple sclerosis	3.28e-05	0.00164	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCR1—multiple sclerosis	3.28e-05	0.00164	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—GPR65—multiple sclerosis	3.27e-05	0.00163	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	3.2e-05	0.0016	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CNR1—multiple sclerosis	3.14e-05	0.00157	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RGS1—multiple sclerosis	3.13e-05	0.00156	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—RRM1—multiple sclerosis	3.09e-05	0.00155	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—MAPK1—multiple sclerosis	3.03e-05	0.00151	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TAGAP—multiple sclerosis	3.01e-05	0.0015	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CCR1—multiple sclerosis	2.99e-05	0.00149	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL13—multiple sclerosis	2.99e-05	0.00149	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GPR65—multiple sclerosis	2.97e-05	0.00148	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CCL5—multiple sclerosis	2.95e-05	0.00147	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	2.88e-05	0.00144	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LINGO1—multiple sclerosis	2.87e-05	0.00143	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.85e-05	0.00143	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.85e-05	0.00142	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL10—multiple sclerosis	2.83e-05	0.00142	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.79e-05	0.0014	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—RRM1—multiple sclerosis	2.76e-05	0.00138	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.72e-05	0.00136	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCR1—multiple sclerosis	2.71e-05	0.00136	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL13—multiple sclerosis	2.71e-05	0.00136	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	2.7e-05	0.00135	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.69e-05	0.00135	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.66e-05	0.00133	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.66e-05	0.00133	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CCR5—multiple sclerosis	2.65e-05	0.00133	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—S1PR1—multiple sclerosis	2.63e-05	0.00131	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.62e-05	0.00131	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GPC5—multiple sclerosis	2.56e-05	0.00128	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TAGAP—multiple sclerosis	2.49e-05	0.00124	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PTGER4—multiple sclerosis	2.48e-05	0.00124	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CCL5—multiple sclerosis	2.44e-05	0.00122	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.4e-05	0.0012	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.4e-05	0.0012	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCR3—multiple sclerosis	2.39e-05	0.0012	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCL3—multiple sclerosis	2.34e-05	0.00117	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CCR2—multiple sclerosis	2.33e-05	0.00116	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.25e-05	0.00113	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PTGER4—multiple sclerosis	2.25e-05	0.00113	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RGS1—multiple sclerosis	2.23e-05	0.00112	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.2e-05	0.0011	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CCR5—multiple sclerosis	2.19e-05	0.0011	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—S1PR1—multiple sclerosis	2.17e-05	0.00109	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCR3—multiple sclerosis	2.17e-05	0.00109	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CNR1—multiple sclerosis	2.15e-05	0.00107	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.14e-05	0.00107	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GPR65—multiple sclerosis	2.12e-05	0.00106	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GPC5—multiple sclerosis	2.11e-05	0.00106	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCR2—multiple sclerosis	2.11e-05	0.00106	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—POMC—multiple sclerosis	2.07e-05	0.00104	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—MAPK1—multiple sclerosis	2.06e-05	0.00103	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.06e-05	0.00103	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PTGER4—multiple sclerosis	2.05e-05	0.00102	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CCL2—multiple sclerosis	2.03e-05	0.00102	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	1.98e-05	0.00099	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CNR1—multiple sclerosis	1.95e-05	0.000976	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCR1—multiple sclerosis	1.94e-05	0.000969	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL13—multiple sclerosis	1.94e-05	0.000969	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL10—multiple sclerosis	1.93e-05	0.000967	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	1.93e-05	0.000967	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	1.92e-05	0.000963	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.88e-05	0.00094	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	1.86e-05	0.000931	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	1.85e-05	0.000924	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—MAPK1—multiple sclerosis	1.84e-05	0.00092	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.84e-05	0.00092	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	1.8e-05	0.000899	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—POMC—multiple sclerosis	1.78e-05	0.000891	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	1.78e-05	0.000889	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—BCHE—multiple sclerosis	1.78e-05	0.000889	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.77e-05	0.000884	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL10—multiple sclerosis	1.76e-05	0.000878	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	1.75e-05	0.000876	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	1.75e-05	0.000874	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CCL2—multiple sclerosis	1.74e-05	0.000872	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	1.72e-05	0.000861	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	1.72e-05	0.000858	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	1.68e-05	0.00084	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.68e-05	0.000839	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CCL5—multiple sclerosis	1.66e-05	0.000833	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	1.61e-05	0.000807	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	1.6e-05	0.000802	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	1.6e-05	0.000802	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	1.6e-05	0.0008	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—POMC—multiple sclerosis	1.59e-05	0.000795	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	1.55e-05	0.000778	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	1.51e-05	0.000756	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	1.5e-05	0.00075	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	1.48e-05	0.000739	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	1.45e-05	0.000727	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	1.38e-05	0.000691	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	1.38e-05	0.000689	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	1.36e-05	0.000681	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	1.34e-05	0.000671	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	1.33e-05	0.000665	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.32e-05	0.000661	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PGR—multiple sclerosis	1.31e-05	0.000655	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	1.28e-05	0.000642	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CD28—multiple sclerosis	1.27e-05	0.000636	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	1.25e-05	0.000625	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	1.25e-05	0.000624	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	1.24e-05	0.00062	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.22e-05	0.000612	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	1.17e-05	0.000586	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	1.15e-05	0.000576	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	1.14e-05	0.000571	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	1.13e-05	0.000563	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.11e-05	0.000555	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	1.1e-05	0.00055	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	1.08e-05	0.000541	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOE—multiple sclerosis	1.07e-05	0.000535	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	1.06e-05	0.000532	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	1.06e-05	0.000531	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	1.05e-05	0.000526	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	1.04e-05	0.000521	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	1.04e-05	0.000519	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	1.03e-05	0.000517	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	9.69e-06	0.000485	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOE—multiple sclerosis	9.53e-06	0.000477	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	9.53e-06	0.000477	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	9.46e-06	0.000473	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—POMC—multiple sclerosis	9.18e-06	0.000459	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CD86—multiple sclerosis	9.07e-06	0.000454	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	8.93e-06	0.000447	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	8.8e-06	0.00044	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	8.66e-06	0.000433	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	8.61e-06	0.000431	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	8.58e-06	0.000429	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALB—multiple sclerosis	8.37e-06	0.000419	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	8.27e-06	0.000414	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—POMC—multiple sclerosis	8.19e-06	0.00041	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	8.04e-06	0.000402	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	7.93e-06	0.000397	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	7.87e-06	0.000394	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	7.82e-06	0.000391	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	7.5e-06	0.000375	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALB—multiple sclerosis	7.47e-06	0.000373	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	7.39e-06	0.000369	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOE—multiple sclerosis	7.32e-06	0.000366	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	7.17e-06	0.000358	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	6.84e-06	0.000342	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	6.65e-06	0.000333	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CD80—multiple sclerosis	6.62e-06	0.000331	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	6.56e-06	0.000328	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	6.51e-06	0.000326	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—POMC—multiple sclerosis	6.29e-06	0.000315	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	6.15e-06	0.000308	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	6.05e-06	0.000303	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	6.02e-06	0.000301	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	5.59e-06	0.000279	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	5.47e-06	0.000274	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	5.2e-06	0.00026	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	5.09e-06	0.000255	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	4.98e-06	0.000249	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2—multiple sclerosis	4.65e-06	0.000233	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	4.62e-06	0.000231	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	4.62e-06	0.000231	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	4.4e-06	0.00022	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	3.91e-06	0.000196	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	3.84e-06	0.000192	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	3.82e-06	0.000191	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	3.64e-06	0.000182	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—multiple sclerosis	3.63e-06	0.000182	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	3.63e-06	0.000181	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	3.56e-06	0.000178	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	3.23e-06	0.000162	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	3.01e-06	0.00015	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	3e-06	0.00015	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	2.94e-06	0.000147	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—multiple sclerosis	2.73e-06	0.000137	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	2.26e-06	0.000113	CbGpPWpGaD
